🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Citi adds Assicurazioni Generali to European Focus List, lifts stock PT

Published 04-06-2024, 06:14 pm
ARZGY
-

On Tuesday, Citi updated its outlook on Assicurazioni Generali (BIT:GASI) SpA (G:IM) (OTC: ARZGY), raising its price target to €28.70 from €23.36, while maintaining a Buy rating on the stock. The firm forecasts a 12% compound annual growth rate (CAGR) in earnings per share (EPS) from 2024 to 2026 for the Italian insurer. The updated target represents a 21% increase from the previous figure.

The analyst at Citi believes that Assicurazioni Generali's EPS growth is supported by the introduction of regular share buybacks, a factor not widely anticipated in consensus estimates. Citi's projections are only 4% higher than the consensus for 2026, but the firm sees the potential for further upside. A 2 percentage point improvement in the combined operating ratio (COR) could translate to a 12% EPS upgrade.

Citi also points to the potential for retained capital to provide additional value that has not been fully recognized. The firm suggests that this could lead to a 22% increase in value over a three-year period. The forecast for Assicurazioni Generali's free cash flow (FCF) is more optimistic than the consensus, with expectations of higher than anticipated remittances.

Additional positive factors include faster growth in property and casualty (P&C) operating free generation (OFG) and improved cash conversion.

The firm emphasizes the strength of Assicurazioni Generali's business model, which focuses on optimizing existing operations and efficient capital deployment. In light of these factors, Citi has added Assicurazioni Generali to its European Focus List, indicating a favorable outlook for the company's stock among its European equity recommendations.

InvestingPro Insights

Complementing the optimistic outlook from Citi, recent data from InvestingPro reflects a robust financial position for Assicurazioni Generali (OTC: ARZGY). With a market capitalization of $39.99 billion and a trailing P/E ratio as of Q4 2023 at 9.47, the company presents as a potentially undervalued player in the insurance industry. This is further underscored by a PEG ratio of 0.14, suggesting that the stock trades at a low price relative to near-term earnings growth. The revenue growth of 12.75% in the last twelve months as of Q4 2023, combined with a gross profit margin of 17.82%, points to Assicurazioni Generali's capacity for generating earnings efficiently.

An InvestingPro Tip worth noting is the company's low price volatility, which may appeal to investors seeking stability. Additionally, Assicurazioni Generali has demonstrated a commitment to shareholder returns, maintaining dividend payments for 33 consecutive years, with a dividend yield as of mid-2024 standing at 3.55%. For those interested in further insights, InvestingPro offers additional tips on Assicurazioni Generali's performance and potential, which can be accessed through their platform. To gain a deeper understanding and access these additional tips, readers can use the coupon code PRONEWS24 to get an extra 10% off a yearly or biyearly Pro and Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.